上海市胸科医院创建于1957年，是新中国第一家以诊治心胸疾病为主的三级甲等专科医院，我国心胸外科四大先驱中的三位：黄家驷教授、兰锡纯教授和顾恺时教授，担任首任院长、副院长。同年即被国家卫生部指定为全国心胸外科进修基地，培养了数以千计的心胸专科医师，造就了“中国心胸专科人才的摇篮”。2004年冠名上海市红十字胸科医院，2005年成为欧洲杯竞猜平台附属胸科医院。
医院核定床位580张，开放床位1000余张，设有10个临床科室、10个医技科室，病区28个，还建有SICU、CCU、RICU、日间病房、临床研究病房和MDT病房。职工近1500人，其中正副主任医师160余名，博导25名，硕导44名。现有国家级高层次人才计划入选者近40人。
医院聚焦胸部肿瘤与心血管疾病两大学科群，掌握国内疾病谱最广、门类最全的心胸疾病诊治技术。年门急诊量逾85万人次，手术量超2万例，三四级手术比例90%以上，居上海市级医院首位，食管、气管、纵隔肿瘤手术量居全国第一，肺部肿瘤手术量居全国第二。医院擅长各类胸部疾病外科治疗以及肺移植手术，微创外科手术技术处于全国先进水平，达芬奇机器人胸部手术量连续多年保持单中心全国第一。在国内最早开展肺癌的早期诊断、多学科综合治疗、靶向治疗及免疫治疗等前沿技术，开展最高难度（四级）呼吸内镜技术，在国内率先开展超声支气管镜、荧光支气管镜、电磁导航支气管镜、海博技术等治疗肺癌，多次牵头制订肺癌诊疗相关临床指南。医院在复杂冠心病的内外科治疗、心肺血管结构异常的介入治疗、心脏起搏技术、心脏瓣膜手术、终末期心力衰竭内外科综合治疗等领域均处于国内领先地位，经导管主动脉瓣置入术、左心耳封堵术等前沿技术达国内一流水平，房颤射频消融手术量多年位居亚太地区前列。
医院有上海市胸部肿瘤研究所、心肺血管转化研究中心、中心实验室、生物样本库四大科研支撑平台，并建有高新技术转化园区，承担国家863攻关课题、国家科技部重大研发计划、国家自然科学基金重点项目等国家级科研项目。医院拥有独立的临床研究中心，建有肺癌、食管癌、纵隔肿瘤三大专病数据库，开展I期临床试验、器械临床试验、研究者发起的临床研究等，牵头肿瘤临床试验数量在全国名列前茅。
医院是国家卫生部冠脉介入、心律失常、结构性心脏病介入诊疗培训基地，卫生部呼吸内镜培训基地，国家住院医师和专科医师规范化培训基地。建有达芬奇机器人手术临床教学示范中心、腔镜实训中心、心血管急救等具有专科特色的医学模拟中心，获RCS认证及AHA认证。被亚洲胸腔镜教育委员会授予中国大陆唯一一家示范中心。
Shanghai Chest Hospital
Shanghai Chest Hospital, the earliest established Grade-A tertiaryspecialized hospitals in China. The three pioneers of cardiothoracic surgery in China: Professor Huang Jiasi, Professor Lan Xichun and Professor Gu Kaishi served as the first president and vice president. It was designated as the National cardiothoracic surgery training base by the Ministry of Health, which has trained thousands of cardiothoracic specialists and became "the cradle of Chinese cardiothoracic specialist talents". In 2004, the hospital became the Shanghai Red Cross Chest Hospital. In 2005, it became the affiliated hospital of Shanghai Jiao Tong University.
The hospital has 580 approved beds, more than 1000 open beds, 10 clinical departments, 10 medical technology departments, 28 wards, and also has SICU, CCU, RICU, day-care wards, clinical research ward and MDT ward. There are nearly 1500 employees, including more than 160 chief doctors and deputy chief doctors, 25 doctoral supervisors and 44 master supervisors, more than 40 National special support plan for high-level talents.
The hospital focuses on thoracic tumor and cardiovascular disease, and has mastered the diagnosis and treatment technology of cardiothoracic diseases with the widest spectrum and the most complete range of diseases in China. The annual number of outpatient and emergency visits exceeds 850000, surgery volume exceeds 20,000 cases. The proportion of Grade Ⅲ and Grade IV surgeries is more than 90%, ranking first in Shanghai hospitals. The hospital is good at the surgical treatment and lung transplantation of various chest diseases. The minimally invasive surgical technology is at the national advanced level. The amount of robotic chest surgery in Da Vinci has been ranked first in a single center in China for many consecutive years. In the earliest diagnosis of lung cancer, multidisciplinary comprehensive treatment, targeted treatment and immunotherapy cutting-edge technology, carry out the highest difficulty (level 4) respiratory endoscopic technology, take the lead in domestic ultrasonic bronchoscopy, fluorescent bronchoscopy, electromagnetic navigation bronchoscopy, Haibo technology treatment of lung cancer, repeatedly lead the clinical related to lung cancer diagnosis and treatment guidelines. It takes a leading position on interventional therapy of complex coronary heart disease, comprehensive treatment of atrial fibrillation (radiofrequency ablation, left atrial appendage occlusion, anticoagulation and etc), interventional treatment of abnormal cardiopulmonary vascular structure, advanced cardiac pacing technique, end-stage heart failure and etc. The number of radiofrequency ablation surgeries of atrial fibrillation has been ranking NO.1 in the Asia-Pacific region for many years.
Shanghai Chest Hospital has the Shanghai Thoracic Oncology Research Institute, central laboratory, Cardiopulmonary Vascular Translational Research Center, bio-bank, National Drug Clinical Trial Institute and a high-tech transformation park. The hospital also undertakes the key research and development projects of Ministry of Science and Technology of the People’s Republic of China, national 863 key research projects and key projects of National Nature Science Foundation of China. The hospital has an independent clinical research center, a database of lung cancer, esophageal cancer and mediastinal tumor, and carries out phase I clinical trials, instrument clinical trials, and clinical research initiated by researchers, etc. The number of leading tumor clinical trials is among the top in China.
The hospital is the training base for interventional diagnosis and coronary intervention, arrhythmia and structural heart disease, the training base for respiratory endoscopy training of the Ministry of Health, and the national standardized training base for residents and specialists. It has built medical simulation centers with specialized characteristics such as Da Vinci robot surgery clinical teaching demonstration center, endoscopic training center, and center of cardiovascular first aid, and has won RCS certification and AHA certification. Granwarded the only demonstration center of Chinese mainland by the Asian Thoracoscopic Education Council.
